Blood Warming Before Transfusion
Blood should be warmed to 37°C when transfusing volumes of 500 mL or more in all adults undergoing surgery, and warming is essential in massive transfusion scenarios to prevent hypothermia-related coagulopathy and mortality. 1, 2
When Blood Warming is Mandatory
Blood warming is required in the following clinical situations:
- All adults undergoing elective or emergency surgery (including trauma) under general or regional anesthesia receiving ≥500 mL of intravenous fluids or blood components 1, 2
- Massive transfusion scenarios where rapid infusion devices are used (capable of 6-30 L/hour) 1, 2
- Rapid transfusion of large volumes to neonates, children, elderly patients, and patients with cardiac dysfunction 1, 2
- Patients with cardiovascular instability requiring rapid volume resuscitation, as hypothermia worsens hemodynamic instability and coagulopathy 3
Critical Rationale: Why Warming Matters
The evidence strongly supports blood warming based on mortality and morbidity outcomes:
- Hypothermia (<35°C) is an independent risk factor for mortality in trauma patients requiring massive transfusion 1, 3
- Severe hypothermia (<34°C) occurred in 80% of non-survivors versus only 36% of survivors in massive transfusion patients 3
- Each 1°C drop in body temperature causes a 10% reduction in coagulation factor function, creating refractory coagulopathy despite adequate blood product replacement 2, 3
- Patients who were hypothermic and acidotic developed clinically significant bleeding despite adequate blood, plasma, and platelet replacement 3
Equipment Requirements
Blood warming must be performed using specific, approved equipment:
- Only use approved, specifically designed blood warming equipment with a visible thermometer and audible warning system 1, 4
- Devices must be regularly maintained and CE-marked for safety 1, 4
- Monitor settings regularly throughout transfusion to ensure consistent warming 1, 4
- For massive transfusion, use rapid infusion devices that incorporate blood-warming capability (typically 6-30 L/hour capacity) 1, 2
What NOT to Use
Never warm blood using improvised methods including:
These methods cause uncontrolled heating leading to hemolysis, loss of clotting factors, and potential bacterial contamination from bag compromise 4. Water temperatures above 40°C (104°F) cause direct harm to blood cells, and unmonitored warming creates hot spots that destroy cellular components 4.
Target Temperature and Monitoring
- Warm blood components to 37°C using controlled warming devices 1, 2
- Maintain patient core temperature ≥36°C during massive transfusion 1
- Monitor patient temperature every 5 minutes during active resuscitation 1
- Cease rewarming after patient reaches 37°C, as temperatures above this range are associated with poor outcomes and increased mortality 1
Clinical Context: Relative Benefit by Blood Component
The greatest benefit comes from warming red blood cells stored at 4°C rather than platelets (stored at 22±2°C) or FFP/cryoprecipitate (thawed to 37°C) 1, 2. However, there is no evidence that infusing platelets or FFP through a blood warmer is harmful 1.
When Warming May Not Be Necessary
In most clinical situations without the above risk factors, allowing blood to rise to ambient temperature before transfusion is sufficient 1. Blood warming is seldom necessary or desirable for elective transfusions at conventional rates, even for patients with cold autoagglutinins 5.
Common Pitfalls to Avoid
- Do not delay transfusion in hypotensive patients due to mild temperature elevation (e.g., 99.7°F), as this does not represent a contraindication and hypothermia from cold blood is the greater risk 2
- Do not use blood warmers set at 41.5°C with compression sleeves at 300 mmHg, as this combination fails to achieve adequate warming (outlet temperature only 33.7°C) and does not prevent hypothermia risk 6
- Do not assume all blood warmers are equally effective—only single-channel countercurrent heat exchangers meet efficiency requirements for massive transfusion scenarios 7
- Remember that hypothermia prevention is more critical than treating established hypothermia, as refractory coagulopathy develops rapidly once core temperature drops below 34°C 3